# Evaluation of Molecular Markers in Adrenal Tumors

> **NCT01348698** · — · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 74 (actual)

## Conditions studied

- Adrenal Gland Neoplasms

## Interventions

- **PROCEDURE:** Tumor tissue biopsy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01348698
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05-04
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-01-12
- **Target enrollment:** 74 (ACTUAL)
- **Why stopped:** Slow/insufficient accrual
- **Last updated:** 2018-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348698, "Evaluation of Molecular Markers in Adrenal Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01348698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*